Earlier this month, the Office of Cannabis Management released draft regulations governing testing laboratories that plan to enter the retail marijuana marketplace.
The rules are somewhat lengthy – clocking in around 50 pages – and detail requirements around sampling, auditing, personnel and more.
Right now, there are only a few labs in the state testing New York’s medical cannabis. When the adult-use marketplace opens with an estimated thousand or more retail outlets, more labs will be necessary to ensure proper testing and consumer safety.
Bob Miller is the CEO of science and operations at ACT LAB, New York’s first commercial cannabis testing lab which opened around the same time as the state’s own laboratory — the Wadsworth Center. ACT LAB operates in five other states — soon to be seven — and Miller has extensive experience working with government regulators.
NY Cannabis Insider asked Miller to go over the OCM’s new laboratory regulations to provide feedback and insight. What follows is a Q&A with Miller…